Paper - WANFANG MED ONLINE

You Position: Home > Paper

Extraintestinal manifestations of inflammatory bowel disease

( views:20, downloads:0 )

Author:: No author available

Journal Title:: World Chinese Journal of Digestology

Issue:: 1

DOI:: 10.11569/wcjd.v24.i1.1

Key Word:: 炎症性肠病;肠外表现;溃疡性结肠炎;Inflammatory bowel disease;Extraintestinal manifestations;Ulcerative colitis

Abstract：炎症性肠病(inflammatory bowel disease,IBD)是一种系统性疾病,不仅累及肠道,亦可出现多种肠外表现(extraintestinal manifestations,EIMs).EIMs涉及多个系统.本文总结IBD的肠外表现及其治疗,提高对IBD的认识,并更全面指导临床诊疗.

Reference

[1]K M, Das.Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis.[J].1999,44(1).
[2]Adam V. Weizman,Brian Huang,Stephan Targan,etc.Pyoderma Gangrenosum among Patients with Inflammatory Bowel Disease: A Descriptive Cohort Study[J].2015,19(2).
[3]T R Orchard,B P Wordsworth,D P Jewell.Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history[J].1998,42(3).
[4]Dídia Bismara, Cury,Alan C, Moss,Nestor, Schor.Nephrolithiasis in patients with inflammatory bowel disease in the community.[J].2013,6.
[5]Brannagan TH 3rd,Sander HW,Chin RL,etc.Peripheral neuropathy in patients with inflammatory bowel disease.[J].2005,128(Pt.4).
[6]Joseph B Felder,Burton I Korelitz,Ramona Rajapakse,etc.Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study[J].2000,95(8).
[7]Uma Mahadevan,Edward V Loftus Jr,William J Tremaine,etc.Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease[J].2002,97(4).
[8]Wieser,V.,Gerner,R.,Moschen,A.R.,etc.Liver complications in inflammatory bowel diseases[J].2013,31(2).
[9]Gizard,E.,Ford,A.C.,Bronowicki,J.-P.,etc.Systematic review: The epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease[J].2014,40(1).
[10]Veloso Fernando Tavarela,Carvalho Jo\u00e4o,Magro Fernando.Immune-Related Systemic Manifestations of Inflammatory Bowel Disease[J].1996.
[11]S V, Louren?o,T P, Hussein,S B, Bologna,etc.Oral manifestations of inflammatory bowel disease: a review based on the observation of six cases.[J].2010,24(2).
[12]M A, Brink,J F, Slors,Y C, Keulemans,etc.Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease.[J].1999,116(6).
[13]Rosy Wang,Rupert Leong.Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: A review of the literature[J].2014,(27).
[14]Ho-Su, Lee,Kyung-Wook, Jo,Tae Sun, Shim,etc.Six Cases of Lung Injury Following Anti-tumour Necrosis Factor Therapy for Inflammatory Bowel Disease.[J].2015,9(11).
[15]Corica, Domenico,Romano, Claudio.Renal Involvement in Inflammatory Bowel Diseases[J].2016,10(2).
[16]Xin Geng*,Livia Biancone‡,Hui Hui Dai§,etc.Tropomyosin isoforms in intestinal mucosa: Production of autoantibodies to tropomyosin isoforms in ulcerative colitis[J].1998,114(5).
[17]T Card,J West,R Hubbard,etc.Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study[J].2004,53(2).
[18]Hugh Black,Mark Mendoza,Susan Murin.Thoracic Manifestations of Inflammatory Bowel Disease[J].2007,131(2).
[19]Adriani,A.,Pantaleoni,S.,Luchino,M.,etc.Osteopenia and osteoporosis in patients with new diagnosis of inflammatory bowel disease[J].2014,56(2).
[20]Scherl E,Rubin PH,Friedman S,etc.Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease.[J].2001,7(1).
[21]S Generini,R Giacomelli,R Fedi,etc.Infliximab in spondyloarthropathy associated with Crohn’s disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations[J].2004,63(12).
[22]Quin A,Kane S,Ulitsky O.A case of fistulizing Crohn's disease and erythema nodosum managed with adalimumab.[J].2008,5(5).
[23]Basit,S.,Wohlfahrt,J.,Jess,T.,etc.Risk of ischaemic heart disease in patients with inflammatory bowel disease: A nationwide Danish cohort study[J].2013,62(5).
[24]Ambruzs,J.M.,Walker,P.D.,Larsen,C.P..The histopathologic spectrum of kidney biopsies in patients with inflammatory bowel disease[J].2014,9(2).
[25]Sheldon David G..Twenty Cases of Peristomal Pyoderma Gangrenosum[J].2000.
[26]C, Manganelli,S, Turco,E, Balestrazzi.Ophthalmological aspects of IBD.[J].2009,13 Suppl 1.
[27]D O, Clegg,D J, Reda,M, Abdellatif.Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study.[J].1999,42(11).
[28]Zaira, Pellicer,Jesus Manuel, Santiago,Alejandro, Rodriguez,etc.Management of cutaneous disorders related to inflammatory bowel disease.[J].2012,25(1).
[29]Hussain, Issa,Sami, Al-Momen,Bahaa, Bseiso,etc.Thromboembolism in inflammatory bowel diseases: a report from Saudi Arabia.[J].2011,4.
[30]Ian R Sanderson.Growth problems in children with IBD.[J].2014,11(10).
[31]Phillip, Ruisi,John N, Makaryus,Michael, Ruisi,etc.Inflammatory bowel disease as a risk factor for premature coronary artery disease.[J].2015,7(4).
[32]Xiao-Qing Ji,Li-Xia Wang,De-Gan Lu.Pulmonary manifestations of inflammatory bowel disease[J].2014,(37).
[33]Jorgensen R,Kowdley KV,Luketic VA,etc.High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.[J].2011,106(9).
[34]Han,A.,Su,L.,Davis,M.,etc.Virus-Specific CD4+ Memory-Phenotype T Cells Are Abundant in Unexposed Adults[J].2013,38(2).
[35]Songur N,Songur Y,Tuzun M,etc.Pulmonary Function Tests and High-Resolution CT in the Detection of Pulmonary Involvement in Inflammatory Bowel Disease.[J].2003,37(4).
[36]Calvo,P.,Pablo,L..Managing IBD outside the gut: Ocular manifestations[J].2013,31(2).
[37]Tavarela Veloso F.Skin complications associated with inflammatory bowel disease.[J].2004,20(Suppl 4).
[38]F, Van den Bosch,E, Kruithof,M, De Vos,etc.Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms.[J].2000,356(9244).